<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="10" family="Symbol" color="#000000"/>
	<fontspec id="font6" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font7" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font8" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font9" size="9" family="GillSans,BoldItalic" color="#000000"/>
<text top="41" left="55" width="110" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Nuclear Receptor 2005, 3 :1<i>Nuclear Receptor</i></text>
<text top="41" left="370" width="184" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.nuclear-receptor.com/content/3/1/1</text>
<text top="756" left="503" width="51" height="10" font="font1" id="p1_t3" reading_order_no="106" segment_no="13" tag_type="text">Page 9 of 11<b>3</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="107" segment_no="14" tag_type="text">(page number not for citation purposes)</text>
<text top="87" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="text">DR-3 (VDRE), this hypothesis is not strongly supported</text>
<text top="95" left="55" width="241" height="13" font="font4" id="p1_t6" reading_order_no="3" segment_no="2" tag_type="text">by the results from this study, as PPAR γ -RXR α heterodim-</text>
<text top="110" left="55" width="241" height="9" font="font4" id="p1_t7" reading_order_no="4" segment_no="2" tag_type="text">ers bind normally to DNA in the presence of uremic<i>(page number not for citation purposes)</i></text>
<text top="122" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="2" tag_type="text">plasma. Another alternative that can not be excluded is an</text>
<text top="134" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="2" tag_type="text">inhibitory effect of the uremic toxin on the surface of TR</text>
<text top="145" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="7" segment_no="2" tag_type="text">and VDR DNA binding domain (DBD), disrupting its</text>
<text top="157" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="8" segment_no="2" tag_type="text">ability to binding to DNA. Patel et al. attributed to the for-</text>
<text top="169" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="9" segment_no="2" tag_type="text">mation of Schiff bases between "reactive aldehydes" and</text>
<text top="181" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="2" tag_type="text">lysine residues of the DBD of the VDR to explain the</text>
<text top="192" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="11" segment_no="2" tag_type="text">inhibitory effect of the uremic ultrafiltrate on the binding</text>
<text top="204" left="55" width="241" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="2" tag_type="text">of VDR to DNA [26]. Nevertheless, in another study, point</text>
<text top="216" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="13" segment_no="2" tag_type="text">mutagenesis of different lysine residues in the DBD could</text>
<text top="228" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="14" segment_no="2" tag_type="text">not confirm this idea [28]. In addition, we should con-</text>
<text top="239" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="15" segment_no="2" tag_type="text">sider that the uremic toxins can interact with TR and VDR,</text>
<text top="251" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="2" tag_type="text">causing structural conformational changes on these recep-<i>et al. </i></text>
<text top="263" left="55" width="229" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="2" tag_type="text">tors, consequently, impairing heterodimers formation.</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="5" tag_type="text">We attempted to demonstrate the physiological relevance</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="19" segment_no="5" tag_type="text">of these results by examining the effect of uremic toxins</text>
<text top="310" left="55" width="241" height="10" font="font4" id="p1_t23" reading_order_no="20" segment_no="5" tag_type="text">on T 3 transcriptional activation. Our results showed that</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="21" segment_no="5" tag_type="text">uremic ultrafiltrate collected before hemodialysis inhib-<a href=""> [26</a>]. Nevertheless, in another study, point</text>
<text top="333" left="55" width="241" height="11" font="font4" id="p1_t25" reading_order_no="22" segment_no="5" tag_type="text">ited T 3 -induced transcriptional activation, confirming the</text>
<text top="345" left="55" width="241" height="9" font="font6" id="p1_t26" reading_order_no="23" segment_no="5" tag_type="text">in vitro findings. Conversely, in the presence of ultrafiltrate<a href="">[28]. </a>In addition, we should con-</text>
<text top="357" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="24" segment_no="5" tag_type="text">collected after hemodialysis, the transcriptional activation</text>
<text top="369" left="55" width="241" height="10" font="font4" id="p1_t28" reading_order_no="25" segment_no="5" tag_type="text">induced by T 3 was similar to the control group treated</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="26" segment_no="5" tag_type="text">with ultrafiltrate collected from normal individuals.</text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="27" segment_no="5" tag_type="text">Therefore, we hypothesize that dialyzable toxins are</text>
<text top="404" left="55" width="241" height="10" font="font4" id="p1_t31" reading_order_no="28" segment_no="5" tag_type="text">responsible for the resistance to T 3 action documented in</text>
<text top="416" left="55" width="56" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="5" tag_type="text">CRF patients.</text>
<text top="439" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="6" tag_type="text">In summary, uremic toxins circulating in the plasma of</text>
<text top="448" left="55" width="241" height="13" font="font4" id="p1_t34" reading_order_no="31" segment_no="6" tag_type="text">CRF patients selectively reduced the binding of TR β 1-</text>
<text top="460" left="55" width="241" height="13" font="font4" id="p1_t35" reading_order_no="32" segment_no="6" tag_type="text">RXR α to DNA and impaired the TR β 1 transcriptional acti-</text>
<text top="474" left="55" width="241" height="11" font="font4" id="p1_t36" reading_order_no="33" segment_no="6" tag_type="text">vation mediated by T 3 . Moreover, hemodialysis partially</text>
<text top="486" left="55" width="241" height="9" font="font4" id="p1_t37" reading_order_no="34" segment_no="6" tag_type="text">corrected this inhibitory effect, suggesting the presence of</text>
<text top="495" left="55" width="241" height="13" font="font4" id="p1_t38" reading_order_no="35" segment_no="6" tag_type="text">a dialyzable toxin. Since TR β 1 functions as a heterodimer</text>
<text top="507" left="55" width="241" height="13" font="font4" id="p1_t39" reading_order_no="36" segment_no="6" tag_type="text">with RXR α , these findings might explain some features of<i>in vitro </i></text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="37" segment_no="6" tag_type="text">hypothyroidism and thyroid hormone resistance com-</text>
<text top="533" left="55" width="241" height="9" font="font4" id="p1_t41" reading_order_no="38" segment_no="6" tag_type="text">monly found in CRF patients. Future studies are necessary</text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t42" reading_order_no="39" segment_no="6" tag_type="text">to identify the toxins and further characterize the mecha-</text>
<text top="557" left="55" width="239" height="10" font="font4" id="p1_t43" reading_order_no="40" segment_no="6" tag_type="text">nisms involved in resistance to T 3 action in CRF patients.</text>
<text top="580" left="55" width="115" height="10" font="font8" id="p1_t44" reading_order_no="41" segment_no="9" tag_type="title">Materials and methods</text>
<text top="592" left="55" width="135" height="9" font="font9" id="p1_t45" reading_order_no="42" segment_no="10" tag_type="title">Patients and Clinical Procedures</text>
<text top="604" left="55" width="241" height="9" font="font4" id="p1_t46" reading_order_no="43" segment_no="11" tag_type="text">Four patients from the chronic dialysis program of</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t47" reading_order_no="44" segment_no="11" tag_type="text">Soclimed Dialysis Clinic were enrolled in our study. All</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t48" reading_order_no="45" segment_no="11" tag_type="text">patients were men whose age ranged from 19 to 43 years</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t49" reading_order_no="46" segment_no="11" tag_type="text">with the mean age being 34 years. They appeared well</text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t50" reading_order_no="47" segment_no="11" tag_type="text">nourished and clinically and laboratorial euthyroid; none</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t51" reading_order_no="48" segment_no="11" tag_type="text">had a history of thyroid disease, thyroid hormone</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t52" reading_order_no="49" segment_no="11" tag_type="text">therapy, treatment with amiodarone or clinically detecta-</text>
<text top="686" left="55" width="241" height="9" font="font4" id="p1_t53" reading_order_no="50" segment_no="11" tag_type="text">ble goiter. Etiology of their chronic renal failure was as fol-</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t54" reading_order_no="51" segment_no="11" tag_type="text">lows: chronic glomerulonephritis (2); hypertension (1);</text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t55" reading_order_no="52" segment_no="11" tag_type="text">reflux nephropathy (1). Mean plasma urea level was 178</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t56" reading_order_no="53" segment_no="11" tag_type="text">± 44.8 mg/dL (120 to 233 mg/dL), while that of creatinine</text>
<text top="87" left="313" width="241" height="9" font="font4" id="p1_t57" reading_order_no="54" segment_no="3" tag_type="text">was 12.6 ± 2.7 mg/dL (9.9 to 16.3 mg/dL). Patients were</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="3" tag_type="text">on hemodialysis 3 times a week, during 4 hours using a</text>
<text top="110" left="313" width="242" height="9" font="font4" id="p1_t59" reading_order_no="56" segment_no="3" tag_type="text">1.8 m 2 Fresenius ® Polysulfone filter. Normal control sub-</text>
<text top="122" left="313" width="241" height="9" font="font4" id="p1_t60" reading_order_no="57" segment_no="3" tag_type="text">jects consisted of three healthy men, age ranging from 23</text>
<text top="134" left="313" width="241" height="9" font="font4" id="p1_t61" reading_order_no="58" segment_no="3" tag_type="text">to 41 years, with the mean age of 32 years. The experimen-</text>
<text top="145" left="313" width="241" height="9" font="font4" id="p1_t62" reading_order_no="59" segment_no="3" tag_type="text">tal protocol was approved by the Human Rights in</text>
<text top="157" left="313" width="241" height="9" font="font4" id="p1_t63" reading_order_no="60" segment_no="3" tag_type="text">Research Committee of the University of Brasilia and all</text>
<text top="169" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="61" segment_no="3" tag_type="text">patients and normal individuals gave their informed</text>
<text top="181" left="313" width="35" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="3" tag_type="text">consent.</text>
<text top="204" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="63" segment_no="4" tag_type="text">For the in vitro DNA binding assay, uremic plasma was</text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="64" segment_no="4" tag_type="text">collected immediately before and after 4 h of hemodialy-</text>
<text top="225" left="313" width="241" height="13" font="font4" id="p1_t68" reading_order_no="65" segment_no="4" tag_type="text">sis, aliquoted into 20 µ L samples and stocked at -20°C.</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="66" segment_no="4" tag_type="text">Uremic ultrafiltrate (UF) was also collected pre and post 4</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="67" segment_no="4" tag_type="text">h hemodialysis. Lyophilisation was used to concentrate</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="68" segment_no="4" tag_type="text">ultrafiltrate samples. The lyophilisates were re-suspended</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t72" reading_order_no="69" segment_no="4" tag_type="text">in bidistillated water to a 10-fold concentrated solution,</text>
<text top="286" left="313" width="241" height="9" font="font4" id="p1_t73" reading_order_no="70" segment_no="4" tag_type="text">as effects of the UF were not detectable at lower concentra-</text>
<text top="298" left="313" width="241" height="9" font="font4" id="p1_t74" reading_order_no="71" segment_no="4" tag_type="text">tions (1 fold, 2.5 fold, 5 fold concentrated; not shown).</text>
<text top="310" left="313" width="241" height="9" font="font4" id="p1_t75" reading_order_no="72" segment_no="4" tag_type="text">Samples were subsequently desalted by filtration using</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t76" reading_order_no="73" segment_no="4" tag_type="text">Centricon 3 filters. Following centrifugation, the pellet<b>Materials and methods</b></text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t77" reading_order_no="74" segment_no="4" tag_type="text">was re-suspended in RPMI-1640 medium, (10% newborn<i><b>Patients and Clinical Procedures</b></i></text>
<text top="345" left="313" width="241" height="9" font="font4" id="p1_t78" reading_order_no="75" segment_no="4" tag_type="text">bovine serum; 2 mM glutamine; 50 units/mL penicillin;</text>
<text top="354" left="313" width="241" height="13" font="font4" id="p1_t79" reading_order_no="76" segment_no="4" tag_type="text">50 µ g/mL streptomycin) and pH corrected to 7. Normal</text>
<text top="369" left="313" width="241" height="9" font="font4" id="p1_t80" reading_order_no="77" segment_no="4" tag_type="text">UF was collected from control plasma of normal individ-</text>
<text top="380" left="313" width="241" height="9" font="font4" id="p1_t81" reading_order_no="78" segment_no="4" tag_type="text">uals. The treatment solution was prepared in the same</text>
<text top="392" left="313" width="241" height="9" font="font4" id="p1_t82" reading_order_no="79" segment_no="4" tag_type="text">manner as the uremic solution. All experiments were per-</text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t83" reading_order_no="80" segment_no="4" tag_type="text">formed with the uremic sample from the same patient</text>
<text top="416" left="313" width="180" height="9" font="font4" id="p1_t84" reading_order_no="81" segment_no="4" tag_type="text">that showed the strongest inhibitory effect.</text>
<text top="439" left="313" width="93" height="9" font="font9" id="p1_t85" reading_order_no="82" segment_no="7" tag_type="title">Gel shift binding assay</text>
<text top="450" left="313" width="241" height="10" font="font4" id="p1_t86" reading_order_no="83" segment_no="8" tag_type="text">Gel shift assays were used to evaluate the binding of 35 S-</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t87" reading_order_no="84" segment_no="8" tag_type="text">labeled TR synthesized in reticulocyte lysate on 600</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t88" reading_order_no="85" segment_no="8" tag_type="text">fmoles of unlabeled DR-4 (5'-AGCT TC AGGTCA CAGG</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t89" reading_order_no="86" segment_no="8" tag_type="text">AGGTCA GAG -3') and inverted palindrome – F2 (5'-TTC</text>
<text top="497" left="313" width="241" height="10" font="font4" id="p1_t90" reading_order_no="87" segment_no="8" tag_type="text">TGACCC CATTGG AGGTCA GAG -3'); 35 S-labeled VDRs</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t91" reading_order_no="88" segment_no="8" tag_type="text">to unlabeled DR-3 5'- AGCT TC AGGTCA AGG AGGTCA</text>
<text top="518" left="313" width="241" height="13" font="font4" id="p1_t92" reading_order_no="89" segment_no="8" tag_type="text">GAG - 3') and 35 S-labeled PPAR γ to unlabeled DR-1 (5'-</text>
<text top="533" left="313" width="241" height="9" font="font4" id="p1_t93" reading_order_no="90" segment_no="8" tag_type="text">AGCT TC AGGTCA G AGGTCA GAG - 3'). Sensitivity and</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t94" reading_order_no="91" segment_no="8" tag_type="text">specificity of this assay have been previously characterized</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t95" reading_order_no="92" segment_no="8" tag_type="text">[23]. Briefly, the labeled protein will migrate in the non-</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t96" reading_order_no="93" segment_no="8" tag_type="text">denaturating polyacrylamide gel only when bound to</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t97" reading_order_no="94" segment_no="8" tag_type="text">DNA. Additionally, gel shift were also performed using</text>
<text top="591" left="313" width="206" height="10" font="font4" id="p1_t98" reading_order_no="95" segment_no="8" tag_type="text">unlabeled synthesized TRs and 32 P-labeled DR-4.</text>
<text top="615" left="313" width="241" height="9" font="font6" id="p1_t99" reading_order_no="96" segment_no="12" tag_type="text">In vitro receptor synthesis was performed using plasmids</text>
<text top="624" left="313" width="241" height="13" font="font4" id="p1_t100" reading_order_no="97" segment_no="12" tag_type="text">encoding hTR β 1 hRXR α , and hPPAR γ [38] and hVDR [39]</text>
<text top="639" left="313" width="241" height="9" font="font4" id="p1_t101" reading_order_no="98" segment_no="12" tag_type="text">with the TNT-coupled Reticulocyte Lysate System</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t102" reading_order_no="99" segment_no="12" tag_type="text">(Promega, Madison, WI) containing a methionine-free</text>
<text top="659" left="313" width="241" height="13" font="font4" id="p1_t103" reading_order_no="100" segment_no="12" tag_type="text">aminoacid mixture, and either 20 µ M cold methionine or<i>in vitro </i></text>
<text top="671" left="313" width="241" height="13" font="font4" id="p1_t104" reading_order_no="101" segment_no="12" tag_type="text">35 S-labeled methionine. DNA plasmid (0.2–2 µ g) was</text>
<text top="683" left="313" width="241" height="13" font="font4" id="p1_t105" reading_order_no="102" segment_no="12" tag_type="text">added to TNT Quick Master Mix and incubated in 50 µ L</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t106" reading_order_no="103" segment_no="12" tag_type="text">for 90 min at 30°C. To confirm efficiency of the transla-</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t107" reading_order_no="104" segment_no="12" tag_type="text">tion reaction 35 S-labeled translated proteins were ana-</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t108" reading_order_no="105" segment_no="12" tag_type="text">lyzed by sodium dodecyl sulfate gel electrophoresis (SDS-</text>
</page>
</pdf2xml>
